標(biāo)題: Titlebook: Cannabinoids and Neuropsychiatric Disorders; Eric Murillo-Rodriguez,S. R. Pandi-Perumal,Jaime M Book 2021 The Editor(s) (if applicable) an [打印本頁] 作者: 教條 時(shí)間: 2025-3-21 17:25
書目名稱Cannabinoids and Neuropsychiatric Disorders影響因子(影響力)
書目名稱Cannabinoids and Neuropsychiatric Disorders影響因子(影響力)學(xué)科排名
書目名稱Cannabinoids and Neuropsychiatric Disorders網(wǎng)絡(luò)公開度
書目名稱Cannabinoids and Neuropsychiatric Disorders網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cannabinoids and Neuropsychiatric Disorders被引頻次
書目名稱Cannabinoids and Neuropsychiatric Disorders被引頻次學(xué)科排名
書目名稱Cannabinoids and Neuropsychiatric Disorders年度引用
書目名稱Cannabinoids and Neuropsychiatric Disorders年度引用學(xué)科排名
書目名稱Cannabinoids and Neuropsychiatric Disorders讀者反饋
書目名稱Cannabinoids and Neuropsychiatric Disorders讀者反饋學(xué)科排名
作者: 著名 時(shí)間: 2025-3-22 00:15 作者: Synthesize 時(shí)間: 2025-3-22 01:27 作者: 諄諄教誨 時(shí)間: 2025-3-22 05:38 作者: resilience 時(shí)間: 2025-3-22 09:57 作者: locus-ceruleus 時(shí)間: 2025-3-22 14:16 作者: locus-ceruleus 時(shí)間: 2025-3-22 17:04 作者: DAFT 時(shí)間: 2025-3-22 21:33
https://doi.org/10.1007/978-3-662-64129-3n. There is preclinical evidence that alteration in the endocannabinoid system could potentially benefit patients suffering from depression. However, the issue of using cannabis as an anti-depressant is at an early stage of examination and there is little evidence to support it. Finally, there has b作者: VEIL 時(shí)間: 2025-3-23 04:39 作者: Barter 時(shí)間: 2025-3-23 07:24
Keeley C. Harmon,Joe Ann Clark,Vicki Morand seizure conditions. Clinical trials are ongoing for other forms of epilepsy and refractory seizures associated with infantile spasms, tuberous sclerosis, and Rett syndrome. Overall, adjunct CBD has been found to be generally safe and effective for treatment-resistant seizures in children with seve作者: 沒血色 時(shí)間: 2025-3-23 10:48
https://doi.org/10.1007/978-3-030-82875-2le treatment for CUDs. Although major advances have been reported from cannabinoid and ECS research, there are gaps in scientific knowledge on long-term consequences of cannabis use. Adolescent and cannabis use during pregnancy presents further challenges, and more research will uncover the signalin作者: Indelible 時(shí)間: 2025-3-23 16:34 作者: 胰島素 時(shí)間: 2025-3-23 18:17 作者: ureter 時(shí)間: 2025-3-24 00:40
0065-2598 plains the recent advances in the understanding of endocanna.This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues..Archeological evidence has shown that作者: cunning 時(shí)間: 2025-3-24 03:14 作者: 混沌 時(shí)間: 2025-3-24 07:29
https://doi.org/10.1007/978-3-662-64129-3system under certain physiopathological conditions, with a focus on neurological, oncologic, and metabolic disorders. Cannabinoids evaluated as potential therapeutic agents in experimental models with an emphasis in the most successful chemical entities and their perspectives towards the clinic will be discussed.作者: 紅潤(rùn) 時(shí)間: 2025-3-24 13:36
Constituents of ,nds in numerous medical conditions, such as pain, anxiety, epilepsy, nausea and vomiting, and post-traumatic stress disorder. This chapter provides an overview of some of the biological effects of a number of the cannabinoids and terpenes, as well as discussing their known mechanisms of action and evidence of potential therapeutic effects.作者: Modify 時(shí)間: 2025-3-24 16:24
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models,system under certain physiopathological conditions, with a focus on neurological, oncologic, and metabolic disorders. Cannabinoids evaluated as potential therapeutic agents in experimental models with an emphasis in the most successful chemical entities and their perspectives towards the clinic will be discussed.作者: 混沌 時(shí)間: 2025-3-24 19:23 作者: 綁架 時(shí)間: 2025-3-25 01:39
Women and War Work (2): Nursing, The aim of this chapter is to give an overview of the main endogenous and synthetic cannabinoids used for the symptomatic amelioration of MS and their beneficial outcomes, providing new possible perspectives for the treatment of this disease.作者: 生氣地 時(shí)間: 2025-3-25 04:14
https://doi.org/10.1007/978-3-030-57369-02-Arachidonylglycerol; Cannabis Sativa; Cannabis Mode of Action; Depressive Disorder; Effect of Cannabis作者: synchronous 時(shí)間: 2025-3-25 07:53 作者: Respond 時(shí)間: 2025-3-25 12:07 作者: 遺傳 時(shí)間: 2025-3-25 19:30
Eric Murillo-Rodriguez,S. R. Pandi-Perumal,Jaime MProvides insight into the neuromolecular mechanism of action.Highlights the use of cannabis in major neurologic and psychiatric disorders.Explains the recent advances in the understanding of endocanna作者: 補(bǔ)角 時(shí)間: 2025-3-25 20:31
Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/c/image/221311.jpg作者: Meager 時(shí)間: 2025-3-26 02:26
https://doi.org/10.1007/978-88-470-1845-7ified. There are more than 550 chemical compounds in cannabis, with more than 100 phytocannabinoids being identified, including Δ.-tetrahydrocannabinol (THC) and cannabidiol (CBD). These phytocannabinoids work by binding to the cannabinoid receptors, as well as other receptor systems. Also within ca作者: 草率女 時(shí)間: 2025-3-26 06:03 作者: 抱狗不敢前 時(shí)間: 2025-3-26 12:16
https://doi.org/10.1007/978-3-662-60574-5-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Cannabis-based products are used as medicines in several countries. In this text, we present an overview of the main neurochemical mechanisms of action of the phytocannabinoids, especially THC and CBD. We also reviewed the indications and adverse 作者: Interlocking 時(shí)間: 2025-3-26 13:55 作者: forthy 時(shí)間: 2025-3-26 17:26 作者: Neolithic 時(shí)間: 2025-3-26 21:28 作者: Diaphragm 時(shí)間: 2025-3-27 03:32 作者: NOTCH 時(shí)間: 2025-3-27 05:54 作者: 愛管閑事 時(shí)間: 2025-3-27 11:39
https://doi.org/10.1007/978-3-030-82875-2mal and human studies on psychiatric disorders and cannabinoid receptors. We review and present evaluation of the relationship between changes in the ECS and psychiatric disorders. Evidence suggests the existence of a relationship between changes in components of the ECS, and some of the symptoms pr作者: NATAL 時(shí)間: 2025-3-27 15:24 作者: Melodrama 時(shí)間: 2025-3-27 17:59 作者: Confidential 時(shí)間: 2025-3-28 00:45 作者: biopsy 時(shí)間: 2025-3-28 02:28
Neuromolecular Mechanisms of , Action,ough presynaptic CB cannabinoid receptors to regulate neurotransmitter release in the brain, spinal cord and peripheral nerves. CBD action, on the other hand, is probably mediated through multiple molecular targets.作者: medium 時(shí)間: 2025-3-28 07:00
Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review,-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Cannabis-based products are used as medicines in several countries. In this text, we present an overview of the main neurochemical mechanisms of action of the phytocannabinoids, especially THC and CBD. We also reviewed the indications and adverse 作者: 騷擾 時(shí)間: 2025-3-28 13:06 作者: 最后一個(gè) 時(shí)間: 2025-3-28 18:35
Cannabis and Depression, may lead to the onset of depression; however, strong evidence points to the inverse association; i.e. that depression may lead to the onset or increase in cannabis use frequency. Observational and epidemiological studies have not indicated a positive long-term effect of cannabis use on the course a作者: 聾子 時(shí)間: 2025-3-28 21:36 作者: 打谷工具 時(shí)間: 2025-3-29 01:00
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders,s for treatment of drug-resistant epilepsy. In 2018, the FDA approved the use of CBD-rich Epidiolex for two severe forms of epilepsy in children (Lennox-Gastaut and Dravet syndromes). Experimental research supports the use of CBD in many CNS disorders, though the mechanisms underlying its anticonvul作者: Blasphemy 時(shí)間: 2025-3-29 05:38
Cannabinoid-Based Medicines and Multiple Sclerosis,ed by recent studies. MS is a chronic, immune-mediated, and demyelinating disorder of the central nervous system with no cure so far. It is widely reported that cannabinoids might be used to control MS symptoms and that they also might exert neuroprotective effects and slow down disease progression.作者: indifferent 時(shí)間: 2025-3-29 07:26 作者: 表皮 時(shí)間: 2025-3-29 12:16
10樓作者: 摘要 時(shí)間: 2025-3-29 16:58
10樓
